e-learning resources

Prevalence of sub-optimal drug levels of Rifampicin, Isoniazid and Pyrazinamide among tuberculosis patients in Sydney, Australia. A pilot study.

A. Byrne (Sydney (NSW), Australia), R. Wong (Sydney (NSW), Australia), D. Marriott (Sydney (NSW), Australia), D. Kocic (Sydney (NSW), Australia), J. Alffenaar (Sydney (NSW), Australia), J. Cho (Sydney (NSW), Australia), B. Marais (Sydney (NSW), Australia)

Source: International Congress 2022 – Advances in the treatment and clinical/surgical management of tuberculosis and NTM

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Byrne (Sydney (NSW), Australia), R. Wong (Sydney (NSW), Australia), D. Marriott (Sydney (NSW), Australia), D. Kocic (Sydney (NSW), Australia), J. Alffenaar (Sydney (NSW), Australia), J. Cho (Sydney (NSW), Australia), B. Marais (Sydney (NSW), Australia). Prevalence of sub-optimal drug levels of Rifampicin, Isoniazid and Pyrazinamide among tuberculosis patients in Sydney, Australia. A pilot study.. 2630

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.